Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis

References

• Ohri N, Dicker AP, Trabulsi EJ, Showalter TN. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. Eur J Cancer 2012;48:837–44.
   PubMed Web of Science ®Google Scholar
• Connolly JA, Shinohara K, Presti JC, Jr. Carroll PR. Local recurrence after radical prostatectomy: Characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996;47:225–31.
   PubMed Web of Science ®Google Scholar
• Sella T, Schwartz LH, Swindle PW, Onyebuchi CN, Scardino PT, Scher HI, et al. Suspected local recurrence after radical prostatectomy: Endorectal coil MR imaging. Radiology 2004;231:379–85.
   PubMed Web of Science ®Google Scholar
• Silverman JM, Krebs TL. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 1997;168:379–85.
   PubMed Web of Science ®Google Scholar
• Alfarone A, Panebianco V, Schillaci O, Salciccia S, Cattarino S, Mariotti G, et al. Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer. Crit Rev Oncol Hematol 2012;84:109–21.
   PubMed Web of Science ®Google Scholar
• Davis JB, Reiner B, Dusserre A, Giraud JY, Bolla M. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: The dummy run. Radiother Oncol 2002;64:65–73.
   PubMed Web of Science ®Google Scholar
• Miralbell R, Vees H, Lozano J, Khan H, Molla M, Hidalgo A, et al. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys 2007; 67:356–61.
   PubMed Web of Science ®Google Scholar
• King CR. Adjuvant radiotherapy after prostatectomy: Does waiting for a detectable prostate-specific antigen level make sense?Int J Radiat Oncol Biol Phys 2011;80:1–3.
   PubMed Web of Science ®Google Scholar
• King CR, Kapp DS. Radiotherapy after prostatectomy: Is the evidence for dose escalation out there?Int J Radiat Oncol Biol Phys 2008;71:346–50.
   PubMed Web of Science ®Google Scholar
• Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF. Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate- specific antigen levels after radical prostatectomy. J Clin Oncol 1999;17:1155.
   PubMed Web of Science ®Google Scholar
• Chawla AK, Thakral HK, Zietman AL, Shipley WU. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: Analysis of efficacy and prognostic factors. Urology 2002;59:726–31.
   PubMed Web of Science ®Google Scholar
• Cozzarini C, Fiorino C, Da Pozzo LF, Alongi F, Berardi G, Bolognesi A, et al. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: A single-institute analysis of 742 patients. Int J Radiat Oncol Biol Phys 2012;82:191–9.
   PubMed Web of Science ®Google Scholar
• Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:1417–23.
   PubMed Web of Science ®Google Scholar
• Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, et al. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. Eur Urol 2011;60:1142–8.
   PubMed Web of Science ®Google Scholar
• Jereczek-Fossa BA, Zerini D, Vavassori A, Fodor C, Santoro L, Minissale A, et al. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. Int J Radiat Oncol Biol Phys 2009;74:115–25.
   PubMed Web of Science ®Google Scholar
• Kruser TJ, Jarrard DF, Graf AK, Hedican SP, Paolone DR, Wegenke JD, et al. Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence. Cancer 2011;117:2629–36.
   PubMed Web of Science ®Google Scholar
• Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Int J Radiat Oncol Biol Phys 2007;67:1411–7.
   PubMed Web of Science ®Google Scholar
• Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, et al. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results. Eur Urol 2011;60:842–9.
   PubMed Web of Science ®Google Scholar
• Wiegel T, Lohm G, Bottke D, Hocht S, Miller K, Siegmann A, et al. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome – results of a retrospective study. Int J Radiat Oncol Biol Phys 2009;73:1009–16.
   PubMed Web of Science ®Google Scholar
• Ghadjar P, Jackson A, Spratt DE, Oh JH, Munck AF, Rosenschold P, Kollmeier M, et al. Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: Implications for defining postradiotherapy urinary toxicity. Eur Urol Epub 2013 Feb 4.
   Google Scholar
• Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124–9.
   PubMed Web of Science ®Google Scholar
• Ost P, De Gersem W, De Potter B, Fonteyne V, De Neve W, De Meerleer G. A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer. Clin Oncol 2011;23:344–9.
   Web of Science ®Google Scholar
• Panebianco V, Sciarra A, Lisi D, Galati F, Buonocore V, Catalano C, et al. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J Radiol 2012;81:700–8.
   PubMed Web of Science ®Google Scholar
• Sciarra A, Panebianco V, Salciccia S, Osimani M, Lisi D, Ciccariello M, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008;54:589–600.
   PubMed Web of Science ®Google Scholar